Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $626 - $773
63 New
63 $1,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $330,600 - $377,508
-24,951 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $323,614 - $402,958
24,951 New
24,951 $357,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $1.04 Million - $1.41 Million
-76,245 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $1.41 Million - $1.93 Million
-103,841 Reduced 57.66%
76,245 $1.07 Million
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $2.58 Million - $3.37 Million
180,086 New
180,086 $3.38 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.